- Home
- CSBR vs ASPS Comparison
CSBR vs ASPS Comparison
Compare CSBR & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- ASPS
- Stock Information
- Founded
- CSBR 1985
- ASPS 1999
- Country
- CSBR United States
- ASPS Luxembourg
- Employees
- CSBR N/A
- ASPS N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- ASPS Other Consumer Services
- Sector
- CSBR Health Care
- ASPS Consumer Discretionary
- Exchange
- CSBR Nasdaq
- ASPS Nasdaq
- Market Cap
- CSBR 123.2M
- ASPS 123.2M
- IPO Year
- CSBR 1986
- ASPS N/A
- Fundamental
- Price
- CSBR $6.42
- ASPS $12.70
- Analyst Decision
- CSBR Strong Buy
- ASPS
- Analyst Count
- CSBR 1
- ASPS 0
- Target Price
- CSBR $12.00
- ASPS N/A
- AVG Volume (30 Days)
- CSBR 40.7K
- ASPS 27.0K
- Earning Date
- CSBR 09-15-2025
- ASPS 10-23-2025
- Dividend Yield
- CSBR N/A
- ASPS N/A
- EPS Growth
- CSBR N/A
- ASPS N/A
- EPS
- CSBR 0.21
- ASPS N/A
- Revenue
- CSBR $56,878,000.00
- ASPS $168,271,000.00
- Revenue This Year
- CSBR $9.30
- ASPS $38.29
- Revenue Next Year
- CSBR $31.17
- ASPS N/A
- P/E Ratio
- CSBR $29.53
- ASPS N/A
- Revenue Growth
- CSBR 10.11
- ASPS 12.96
- 52 Week Low
- CSBR $3.75
- ASPS $3.46
- 52 Week High
- CSBR $11.99
- ASPS $15.96
- Technical
- Relative Strength Index (RSI)
- CSBR 46.30
- ASPS 68.75
- Support Level
- CSBR $6.27
- ASPS $10.81
- Resistance Level
- CSBR $6.90
- ASPS $13.49
- Average True Range (ATR)
- CSBR 0.29
- ASPS 0.77
- MACD
- CSBR -0.02
- ASPS 0.17
- Stochastic Oscillator
- CSBR 23.37
- ASPS 74.91
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.